-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Docetaxel in Muscle Invasive Bladder Cancer (MIBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Muscle Invasive Bladder Cancer (MIBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Docetaxel in Muscle Invasive Bladder Cancer (MIBC) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Docetaxel in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Docetaxel in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Docetaxel in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Docetaxel in Non Muscle Invasive...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – pVAX-hSlo in Urinary Incontinence
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - pVAX-hSlo in Urinary Incontinence report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PVAX-hSlo in Urinary Incontinence Drug Details: pVAX-hSlo (hmaxi-K) gene transfer therapy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Isatuximab in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Isatuximab in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Isatuximab in Mantle Cell Lymphoma Drug Details: Isatuximab (Sarclisa) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Isatuximab in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Isatuximab in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Isatuximab in Diffuse Large B-Cell Lymphoma Drug Details: Isatuximab (Sarclisa)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Isatuximab in Peripheral T-Cell Lymphomas (PTCL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Isatuximab in Peripheral T-Cell Lymphomas (PTCL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Isatuximab in Peripheral T-Cell Lymphomas (PTCL) Drug Details: Isatuximab (Sarclisa)...
-
Sector Analysis
United Kingdom (UK) Black Friday – Analysing Buying Dynamics, Channel Usage, Spending and Retailer Selection
United Kingdom (UK) Black Friday Market Report Overview The proportion of consumers shopping during the Black Friday promotional period rose marginally by 0.2ppts in 2023. Although shopper penetration increased in 2023, the size of the Black Friday occasions market in the UK is expected to decrease in the coming years. This is due to the falling average consumer spending across several key categories, with notable drops in the electricals & technology and home appliances sector. The UK Black Friday market...
-
Track & Monitor
Insurance Venture Capital Investments in Q2 2023
GlobalData's Insurance VentureView report provides detailed coverage of the global venture capital investment activity in Insurance industry in Q2 2023, covering key insights and trends.
-
Company Profile
The Edrington Group Ltd – Company Profile
The Edrington Group Ltd (Edrington) is a manufacturer of premium spirits. The company distils, coopers, blends, bottles and markets premium spirit brands. Its products include rum, whisky, Scotch and vodka. The company markets its products under the brand names of The Macallan, Brugal, The Famous Grouse, The Glenrothes, Highland Park, Noble Oak, No. 3 London Dry Gin and Naked Malt, among others. Edrington serves through a network of its distribution and marketing teams and distribution partnerships. The company has business...
Add to Basket